DT
NKTR icon

Diversified Trust’s Nektar Therapeutics NKTR Stock Holding History

Diversified Trust’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,014
Closed -$56.2K – 926
2024
Q1 		$56.2K Hold
4,014
– – ﹤0.01% 811
2023
Q4 		$34K Hold
4,014
– – ﹤0.01% 855
2023
Q3 		$35.9K Buy
+4,014
New +$38.6K ﹤0.01% 812

Other funds holding NKTR

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Diversified Trust's NKTR Position: Q2 2024 in Review

Diversified Trust sold out of Nektar Therapeutics (NKTR) in Q2 2024, closing a stake of 4,014 shares — an estimated $56.2K sold.

Diversified Trust first reported a position in NKTR in Q3 2023 and held it in 3 quarters. The position peaked at $56.2K in Q1 2024. 133 funds tracked by Wall St. Rank hold NKTR as of Q2 2024.

  • Diversified Trust reported no remaining Nektar Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Diversified Trust sold 4,014 Nektar Therapeutics shares in Q2 2024, an estimated $56.2K.
  • Diversified Trust first reported a position in Nektar Therapeutics in Q3 2023 and held it in 3 quarters.
  • Diversified Trust's Nektar Therapeutics position peaked at $56.2K in Q1 2024.
  • 133 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2024.

Based on Diversified Trust's 13F filing for Q2 2024, filed 16 Jul 2024.